Tirzepatide
A synthetic, lipid-modified peptide identified in the literature as LY3298176, with GIP and GLP-1 receptor activity in laboratory assays.
Labeled quantities: 10mg · 20mg · 30mg · 40mg · 60mg
View Tirzepatide detailsCollection overview
The compound collection.
17 compounds and blends, with 25 labeled vial sizes. Compare the material identity and quantity before reviewing its batch evidence.
What the collection contains
Horizon Molecular presents peptides, peptide blends and the coenzyme NAD+. The descriptions explain reference identities from scientific literature. Actual supplied forms, blend compositions and batch findings require supplier documentation. Commercial ordering remains closed.
Retatrutide
A synthetic peptide also designated LY3437943, studied in laboratory assays involving GIP, GLP-1 and glucagon receptors.
Labeled quantities: 10mg · 20mg · 30mg · 40mg · 60mg
View Retatrutide detailsBPC-157
A synthetic 15-residue peptide, supplied as an individually labeled material for laboratory identification and analytical work.
Labeled quantities: 10mg
View BPC-157 detailsTB-500
A material offered under the TB-500 designation. Exact sequence and molecular form await supplier confirmation.
Labeled quantities: 10mg
View TB-500 detailsGHK-Cu
A copper complex of the glycyl-histidyl-lysine tripeptide, presented for laboratory analytical characterization.
Labeled quantities: 100mg
View GHK-Cu detailsCJC-1295 / Ipamorelin
A two-component preparation labeled 5 mg CJC-1295 and 5 mg ipamorelin. The exact CJC form awaits supplier documentation.
Labeled quantities: 5mg / 5mg
View CJC-1295 / Ipamorelin detailsTesamorelin
A synthetic peptide analog of growth-hormone-releasing hormone, with a modified amino terminus.
Labeled quantities: 10mg
View Tesamorelin detailsSermorelin
A synthetic 29-residue peptide corresponding to the amino-terminal region of growth-hormone-releasing hormone.
Labeled quantities: 10mg
View Sermorelin detailsMOTS-c
A 16-residue peptide designation originating from a short open reading frame in mitochondrial 12S rRNA.
Labeled quantities: 40mg
View MOTS-c detailsKPV
A tripeptide named for its lysine-proline-valine sequence, suitable for laboratory identity and stability evaluation subject to its specification.
Labeled quantities: 10mg
View KPV detailsSS-31
A synthetic tetrapeptide also known as elamipretide, containing D-arginine and a modified tyrosine residue.
Labeled quantities: 50mg
View SS-31 detailsNAD+
Nicotinamide adenine dinucleotide in its oxidized form, a dinucleotide coenzyme associated with redox reactions.
Labeled quantities: 1000mg
View NAD+ detailsMelanotan II
A synthetic cyclic peptide identified by the Melanotan II designation, distinct from linear melanocortin analogs.
Labeled quantities: 10mg
View Melanotan II detailsSelank
A synthetic seven-residue peptide with the sequence Thr-Lys-Pro-Arg-Pro-Gly-Pro.
Labeled quantities: 10mg
View Selank detailsSemax
A synthetic seven-residue peptide designated Met-Glu-His-Phe-Pro-Gly-Pro in its reference sequence.
Labeled quantities: 10mg
View Semax detailsKLOW
A blend labeled with an 80 mg total quantity. Its component identities and individual amounts await supplier confirmation.
Labeled quantities: 80mg
View KLOW detailsGLOW
A blend labeled with a 70 mg total quantity. Its component identities and individual amounts await supplier confirmation.
Labeled quantities: 70mg
View GLOW detailsThree details to keep separate
Compound identity tells you which named material is listed. Vial size is the label’s stated quantity, not an administration instruction. Batch evidence describes the specific sample, method and findings in an original report. One does not replace the other.
Read the COA review checklist and catalog FAQ, or ask about a specific material.